Joana M. Mack
Associate Professor
Also affiliated: Arkansas Children's Hospital (2018–2025); Pediatric Oncology Group (2019); University of Arkansas Medical Center (2018–2025)
Faculty Researcher
Peds Pediatrics, College of Medicine
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Joana M. Mack is an Associate Professor in the Department of Pediatrics at the University of Arkansas for Medical Sciences. Her research focuses on the study and treatment of vascular malformations and related conditions in children. Mack has published work investigating the pharmacokinetics of bleomycin sclerotherapy for vascular malformations and approaches to managing coagulopathy in patients with these anomalies. She also studies treatment modalities for vascular anomalies of the head and neck. Her recent publications include research on early response markers predicting survival in hemophagocytic lymphohistiocytosis and the effects of predictive equation adoption on spirometry in children with sickle cell disease. Mack's scholarship metrics include an h-index of 9, with 37 total publications and 222 total citations.
Metrics
- h-index: 9
- Publications: 37
- Citations: 227
Selected Publications
-
ReInspire: A Phase 2 Study of Mutant-Selective PI3Kα Inhibitor, RLY-2608, in Adults and Children with PIK3CA-Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (2026)
-
Intracranial Hypotension in Pediatric Oncology Patients Following Lumbar Puncture: A Case Series (2025)
-
Creating a Roadmap for Longitudinal Quality Improvement Training in a Pediatric Residency Program (2025)
-
Burnout, Professional Fulfillment, Support, and Protected Time Among Pediatric Fellowship Program Directors (2025)
-
Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease (2025)
-
Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease (2025)
-
Sociodemographic Characteristics of Patients Seen at Vascular Anomaly Centers in the United States (2025)
-
Hypercoagulability Evaluation in Pediatric Kidney Transplant Recipients to Optimize Outcomes (2024)
-
How we approach coagulopathy with vascular anomalies (2022)
-
Multimodality treatment of vascular anomalies of the head and neck (2022)
-
Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations (2022)
-
How we approach coagulopathy with vascular anomalies. (2021)
-
Analyzing coagulation dynamics during treatment of vascular malformations with thromboelastography (2020)
-
Vascular Anomalies (2019)
-
Effect of sirolimus on coagulopathy of slow‐flow vascular malformations (2019)
Collaboration Network
Top Collaborators
- Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations
- How we approach coagulopathy with vascular anomalies
- Hypercoagulability Evaluation in Pediatric Kidney Transplant Recipients to Optimize Outcomes
- Hypercoagulability Evaluation in Pediatric Kidney Transplant Recipients to Optimize Outcomes
- Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease
Showing 5 of 6 shared publications
- Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations
- Multimodality treatment of vascular anomalies of the head and neck
- Sociodemographic Characteristics of Patients Seen at Vascular Anomaly Centers in the United States
- ReInspire: A Phase 2 Study of Mutant-Selective PI3Kα Inhibitor, RLY-2608, in Adults and Children with PIK3CA-Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation
- Sociodemographic Characteristics of Patients Seen at Vascular Anomaly Centers in the United States
- ReInspire: A Phase 2 Study of Mutant-Selective PI3Kα Inhibitor, RLY-2608, in Adults and Children with PIK3CA-Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation
- Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease
- Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease
- Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations
- Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations
- Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations
- Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations
- Multimodality treatment of vascular anomalies of the head and neck
- Multimodality treatment of vascular anomalies of the head and neck
- Hypercoagulability Evaluation in Pediatric Kidney Transplant Recipients to Optimize Outcomes
- Hypercoagulability Evaluation in Pediatric Kidney Transplant Recipients to Optimize Outcomes
- Hypercoagulability Evaluation in Pediatric Kidney Transplant Recipients to Optimize Outcomes
- Sociodemographic Characteristics of Patients Seen at Vascular Anomaly Centers in the United States
Similar Researchers
Based on overlapping research topics